Current management of colorectal metastases to lung.
Colorectal carcinoma is the second most common visceral cancer in the United States, in both incidence and fatality rate. Of patients with colorectal carcinoma, 45% undergo resection and are cured. In cases of recurrence, 2% are restricted to lung only. A select group of 287 patients over 30 years at Memorial Sloan-Kettering Cancer Center underwent a surgical approach, which produced a survival rate of 40% at 5 years and 32% at 10 years.
McCormack
P M
PM
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Ginsberg
R J
RJ
D000230:Adenocarcinoma / Q000556:secondary / Q000601:surgery; D001984:Bronchial Neoplasms / Q000556:secondary / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000556:secondary* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000601:surgery; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D008175:Lung Neoplasms / Q000556:secondary* / Q000601:surgery; D018579:Patient Selection; D011013:Pneumonectomy; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D014481:United States
D002272:Carcinoembryonic Antigen